What are critical outcome measures for patients receiving pituitary replacement following brain injury?

Pituitary

Volumn 15, Issue 1, 2012, Pages 10-19

  Beca, Sorin G ^a   High Jr , Walter M ^b   Masel, Brent E ^c   Mossberg, Kurt A ^d   Urban, Randall J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c Transitional Learning Center at Galveston   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Brain injury; Cognitive function; Hypopituitarism; Physical function; Pituitary hormone replacement

Indexed keywords

ADENOHYPOPHYSIS HORMONE; ANDROGEN; GONADOTROPIN; GROWTH HORMONE; LEVOTHYROXINE; LIOTHYRONINE; PLACEBO; TESTOSTERONE; TESTOSTERONE ENANTATE; THYROID HORMONE; THYROXINE;

AEROBIC CAPACITY; ANDROGEN THERAPY; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BRAIN INJURY; COGNITIVE DEFECT; DISEASE ASSOCIATION; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS DISEASE; HYPOPITUITARISM; HYPOTHYROIDISM; MEMORY DISORDER; MUSCLE FORCE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; TESTOSTERONE BLOOD LEVEL; VERBAL MEMORY;

BRAIN INJURIES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOPITUITARISM; PITUITARY HORMONES;

EID: 84858161105     PISSN: 1386341X     EISSN: 15737403     Source Type: Journal    
DOI: 10.1007/s11102-008-0133-3     Document Type: Review

References (64)

1. Aleman A, Verhaar HJJ, de Haan EHF et al (1999) Insulin-like growth factor-I and cognitive function in healthy older men. J Clin Endocrinol Metab 84:471-475. doi:10.1210/jc.84.2.471 (Pubitemid 29075671)
2. Creyghton WM, van Dam PS, Koppeschaar HP (2004) The role of the somatotropic system in cognition and other cerebral functions. Semin Vasc Med 4:167-172. doi:10.1055/s-2004-835375 (Pubitemid 39433668)
3. Maruff P, Falleti M (2005) Cognitive function in growth hormone deficiency and growth hormone replacement. Horm Res 64:100-108. doi:10.1159/000089325
4. Arwert LI, Deijen JB, Drent ML (2005) Effects of growth hormone deficiency and growth hormone treatment on quality of life in growth hormone-deficient adults. Front Horm Res 33:196-208 (Pubitemid 43264831)
5. Arwert LI, Veltman DJ, Deijen JB, van Dam PS, Delemarre-van deWaal HA, Drent ML (2005) Growth hormone deficiency and memory functioning in adults visualized by functional magnetic resonance imaging. Neuroendocrinology 82:32-40. doi:10.1159/ 000090123
6. Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J (2004) The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology 29:839-850. doi:10.1016/S0306-4530(03) 00151-3 (Pubitemid 38716109)
7. Lasaite L, Bunevicius R, Lasiene D, Lasas L (2004) Psychological functioning after growth hormone therapy in adult growth hormone deficient patients: endocrine and body composition correlates. Medicina (Kaunas) 40:740-744
8. Leon-Carrion J, Leal-Cerro A, Cabezas FM et al (2007) Cognitive deterioration due to gh deficiency in patients with traumatic brain injury: a preliminary report. Brain Inj 21:871-875. doi: 10.1080/02699050701484849 (Pubitemid 47244203)
9. Benvenga S, Campenni A, Ruggeri RM, Trimarchi F (2000) Clinical review 113: hypopituitarism secondary to head trauma. J Clin Endocrinol Metab 85:1353-1361. doi:10.1210/jc.85.4.1353 (Pubitemid 32289472)
10. Benvenga S, Vigo T, Ruggeri RM, Lapa D, Almoto B, LoGiudice F, Longo M, Blandino A, Campenni A, Cannavo S, Trimarchi F (2004) Severe head trauma in patients with unexplained central hypothyroidism. Am J Med 116(11):767-771 (Pubitemid 38622314)
11. Aimaretti G, Ambrosio MR, Di Somma C et al (2004) Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf) 61:320-326. doi: 10.1111/j.1365-2265.2004.02094.x (Pubitemid 39287060)
12. Aimaretti G, Ambrosio MR, Di Somma C et al (2005) Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. J Clin Endocrinol Metab 90:6085-6092. doi:10.1210/jc.2005-0504 (Pubitemid 41606529)
13. Slawik M, Klawitter B, Meiser E et al (2007) Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J Clin Endocrinol Metab 92:4115-4122. doi:10.1210/jc.2007-0297 (Pubitemid 350074720)
14. Miller KJ, Parsons TD, Whybrow PC et al (2006) Memory improvement with treatment of hypothyroidism. Int J Neurosci 116:895-906. doi:10.1080/ 00207450600550154
15. Walsh JP, Shiels L, Lim EM et al (2003) Combined thyroxine/ liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism. J Clin Endocrinol Metab 88:4543-4550. doi:10.1210/jc.2003-030249 (Pubitemid 37357490)
16. Wekking EM, Appelhof BC, Fliers E et al (2005) Cognitive functioning and well-being in euthyroid patients on thyroxine replacement therapy for primary hypothyroidism. Eur J Endocrinol 153:747-753. doi:10.1530/eje.1.02025 (Pubitemid 43020224)
17. Morley JE, Kaiser F, Raum WJ, Perry HM III, Flood JF, Jensen J, Silver AJ, Roberts E (1997) Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 94(14):7537-7542
18. Beauchet O (2006) Testosterone and cognitive function: current clinical evidence of a relationship. Eur J Endocrinol 155:773-781. doi:10.1530/eje.1. 02306
19. Gouras GK, Xu H, Gross RS, Greenfield JP, Hai B, Wang R, Greengard P (2000) Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci USA 97(3):1202-1205 (Pubitemid 30080836)
20. Papasozomenos SC, Shanavas A (2002) Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-jun nh2- terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for alzheimer's disease. Proc Natl Acad Sci USA 99(3):1140-1145 (Pubitemid 34136460)
21. Salminen EK, Portin RI, Koskinen A, Helenius H, Nurmi M (2004) Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin Cancer Res 10(22):7575-7582 (Pubitemid 39557519)
22. Almeida OP, Waterreus A, Spry N, Flicker L, Martins RN (2004) One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology 29:1071-1081. doi:10.1016/ j.psyneuen.2003.11.002
23. Cherrier MM, Rose AL, Higano C (2003) The effects of combined androgen blockade on cognitive function during the first cycle of intermittent androgen suppression in patients with prostate cancer. J Urol 170:1808-1811. doi:10.1097/01.ju.0000091640.59812.83 (Pubitemid 37254933)
24. Loizides E, Swierzewski MJ, O'neill C, Griesser J, Smith T (2004) Early response time in sexual activity and mood following testosterone gel replacement in hypogonadal males from the testim(R) START study. Rev Urol 6(Suppl 6):S16-S21
25. Amore M (2005) Partial androgen deficiency and neuropsychiatric symptoms in aging men. J Endocrinol Invest 28(11 Suppl Proceedings):49-54
26. Janowsky JS, Chavez B, Orwoll E (2000) Sex steroids modify working memory. J Cogn Neurosci 12:407-414. doi:10.1162/ 089892900562228
27. Cherrier MM, Asthana S, Plymate S, Baker L, Matsumoto AM, Peskind E, Raskind MA, Brodkin K, Bremner W, Petrova A, Latendresse S, Craft S (2001) Testosterone supplementation improves spatial and verbal memory in healthy older men. Neurology 57(1):80-88 (Pubitemid 32634854)
28. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Peskind ER, Raskind MA, Johnson M, Craft S (2005) The role of aromatization in testosterone supplementation: effects on cognition in older men. Neurology 64(2):290-296
29. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM (2004) Free testosterone and risk for Alzheimer disease in older men. Neurology 62(2):188-193 (Pubitemid 38167123)
30. Abbasi AA, Drinka PJ, Mattson DE, Rudman D (1993) Low circulating levels of insulin-like growth factors and testosterone in chronically institutionalized elderly men. J Am Geriatr Soc 41:975-982 (Pubitemid 23262325)
31. Bowen RL, Isley JP, Atkinson RL (2000) An association of elevated serum gonadotropin concentrations and Alzheimer disease? J Neuroendocrinol 12:351-354. doi:10.1046/j.1365-2826.2000.00461.x (Pubitemid 30156528)
32. Hogervorst E, Bandelow S, Combrinck M, Smith AD (2004) Low free testosterone is an independent risk factor for Alzheimer's disease. Exp Gerontol 39:1633-1639. doi:10.1016/j.exger.2004.06.019 (Pubitemid 39576135)
33. Hogervorst E, Bandelow S, Moffat SD (2005) Increasing testosterone levels and effects on cognitive functions in elderly men and women: a review. Curr Drug Targets CNS Neurol Disord 4:531-540
34. Janowsky JS, Oviatt SK, Orwoll ES (1994) Testosterone influences spatial cognition in older men. Behav Neurosci 108:325-332. doi:10.1037/0735-7044.108.2. 325 (Pubitemid 24142694)
35. Young TP, Hoaglin HM, Burke DT (2007) The role of serum testosterone and TBI in the in-patient rehabilitation setting. Brain Inj 21:645-649. doi:10.1080/02699050701210426 (Pubitemid 46993190)
36. Mattsson S, Thomas BJ (2006) Development of methods for body composition studies. Phys Med Biol 51(13):R203-R228 (Pubitemid 43958616)
37. Behn A, Ur E (2006) The obesity epidemic and its cardiovascular consequences. Curr Opin Cardiol 21:353-360. doi: 10.1097/01.hco.0000231406. 84554.96 (Pubitemid 44315069)
38. Mukherjee A, Murray RD, Shalet SM (2004) Impact of growth hormone status on body composition and the skeleton. Horm Res 62(Suppl 3):35-41. doi:10.1159/000080497
39. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA (1997) Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245. doi:10.1530/eje.0.1370240 (Pubitemid 27405107)
40. Satz P, Forney DL, Zaucha K et al (1998) Depression, cognition, and functional correlates of recovery outcome after traumatic brain injury. Brain Inj 12:537-553. doi:10.1080/026990598122313 (Pubitemid 28302003)
41. Pohl PS, Startzell JK, Duncan PW, Wallace D (2000) Reliability of lower extremity isokinetic strength testing in adults with stroke. Clin Rehabil 14:601-607. doi:10.1191/0269215500cr367oa
42. Riddle DL, Finucane SD, Rothstein JM, Walker ML (1989) Intrasession and intersession reliability of hand-held dynamometer measurements taken on brain-damaged patients. Phys Ther 69:182-194
43. Bohannon RW (2001) Dynamometer measurements of hand-grip strength predict multiple outcomes. Percept Mot Skills 93:323-328
44. Hunter M, Tomberlin J, Kirkikis C, Kuna ST (1990) Progressive exercise testing in closed head-injured subjects: comparison of exercise apparatus in assessment of a physical conditioning program. Phys Ther 70:363-371 (Pubitemid 20171790)
45. Mossberg KA, Greene BP (2005) Reliability of graded exercise testing after traumatic brain injury. Submaximal and peak responses. Am J Phys Med Rehabil 84:492-500 (Pubitemid 40840412)
46. Woodhouse LJ, Asa SL, Thomas SG, Ezzat S (1999) Measures of submaximal aerobic performance evaluate and predict functional response to growth hormone (GH) treatment in GH-deficient adults. J Clin Endocrinol Metab 84:4570-4577. doi:10.1210/jc.84.12.4570
47. Cooper KH (1968) A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA 203(3):201-204
48. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM (1982) Two-, Six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 284(6329):1607-1608 (Pubitemid 12105148)
49. Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132(8):919-923
50. Berg K (1971) Heart-rate telemetry for evaluation of the energy expenditure of children with cerebral palsy. Am J Clin Nutr 24:1438-1445
51. MacGregor J (1981) The evaluation of patient performance using long-term ambulatory monitoring technique in the domiciliary environment. Physiotherapy 67(2):30-33
52. Zugck C, Kruger C, Durr S et al (2000) Is the 6-minute walk test a reliable substitute for peak oxygen uptake in patients with dilated cardiomyopathy? Eur Heart J 21:540-549. doi:10.1053/ euhj.1999.1861
53. King S, Wessel J, Bhambhani Y, Maikala R, Sholter D, MaksymowychW (1999) Validity and reliability of the 6 minute walk in persons with fibromyalgia. J Rheumatol 26:2233-2237 (Pubitemid 29487023)
54. Mossberg KA (2003) Reliability of a timed walk test in persons with acquired brain injury. Am J Phys Med Rehabil 82:385-390. doi:10.1097/00002060- 200305000-00014
55. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S (2006) The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 27:287-317. doi:10.1210/er.2004-0022
56. Bushnik T, Englander J, Katznelson L (2007) Fatigue after TBI. Association with neuroendocrine abnormalities. Brain Inj 21: 559-566 (Pubitemid 46993181)
57. Caiozzo VJ, Davis JA, Ellis JF et al (1982) A comparison of gas exchange indices used to detect the anaerobic threshold. J Appl Physiol 53:1184-1189 (Pubitemid 13220604)
58. Ohuchi H, Nakajima T, Kawade M, Matsuda M, Kamiya T (1996) Measurement and validity of the ventilatory threshold in patients with congenital heart disease. Pediatr Cardiol 17:7-14. doi:10.1007/BF02505805 (Pubitemid 26001318)
59. Moritani T, Nagata A, deVries HA, MuroM(1981) Critical power as a measure of physical work capacity and anaerobic threshold. Ergonomics 24:339-350. doi:10.1080/00140138108924856 (Pubitemid 11003710)
60. Bhasin S, Storer TW, Berman N, Callegari C, Clevenger B, Phillips J, Bunnell TJ, Tricker R, Shirazi A, Casaburi R (1996) The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. N Engl J Med 335(1):1-7 (Pubitemid 26230806)
61. Sheffield-Moore M, Urban RJ, Wolf SE et al (1999) Short-term oxandrolone administration stimulates net muscle protein synthesis in young men. J Clin Endocrinol Metab 84:2705-2711. doi: 10.1210/jc.84.8.2705 (Pubitemid 30641997)
62. Snyder PJ, Peachey H, Hannoush P et al (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653. doi:10.1210/jc.84.8.2647 (Pubitemid 30641987)
63. Urban RJ, Bodenburg YH, Gilkison C et al (1995) Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820-E826 (Pubitemid 3005899)
64. Wang C, Swerdloff RS, Iranmanesh A et al (2000) Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 85:2839-2853. doi:10.1210/jc.85.8.2839 (Pubitemid 32269162)